ChoiceSpine® Introduces Blackhawk® Ti 3D Printed Cervical Spacer System for Standalone Use
Gracie Gottlieb | 19 September, 2023
ChoiceSpine LLC, a leading spinal device company based in Knoxville, TN, has received FDA clearance to market the Blackhawk® Ti 3D Printed Cervical Spacer System as a standalone solution. This innovative system utilizes preassembled integrated anchor technology with a cam-locking mechanism and features a BioBond® 3D Printed Titanium porous structure. With its expanded indication, the Blackhawk® Ti Standalone Cervical Spacer System offers significant benefits to patients and surgeons alike.
The Blackhawk® Ti Standalone Cervical Spacer System has sparked enthusiasm within the industry due to its exceptional features and proven efficacy. ChoiceSpine is renowned for its dedication to improving lives through high-quality products and outstanding customer experiences. The addition of the Blackhawk® Ti Standalone Cervical Spacer System to their existing lineup of world-class solutions further strengthens the company's commitment to excellence and innovation.
Dr. Anders Cohen, Lead Design Surgeon, expressed his satisfaction with the Blackhawk® Ti Standalone Cervical Spacer System, stating that it delivers excellent intra and post-operative results for patients who require the anterior cervical approach. The system's wide variety of implant footprints and profiles enables the restoration of disc height and optimal sagittal balancing. Dr. Cohen also highlighted the simplicity of the implant design, which includes integrated bone anchors and instrumentation that reduce surgery time by minimizing the number of steps involved.
Steve Ainsworth, PhD, ChoiceSpine's Executive Vice President of Strategy and Technology, emphasized that the expanded indication for the Blackhawk® Ti Standalone Cervical Spacer System is a logical progression for the product platform. As the first 3D printed system on the market to utilize preassembled integrated anchor technology, Blackhawk® Ti represents one of ChoiceSpine's many advanced 3D printed titanium fusion solutions. This standalone clearance exemplifies ChoiceSpine's commitment to delivering technically superior spinal devices to the market, always prioritizing quality and patient outcomes.
Key Features of the Blackhawk® Ti Standalone Cervical Spacer System:
- ChoiceSpine's proprietary 3D printed BioBond® technology
- Preassembled integrated anchor technology
- Spacious design for bone graft containment and enhanced visualization
- Available in 6° lordotic and convex profile configurations
- Simultaneous, single-step anchor deployment for efficiency
- External locking indication for easy confirmation
ChoiceSpine maintains a strong focus on surgeon-centric product lines that prioritize safety, efficiency, and ease of use. Through collaborative partnerships with physicians and industry experts, the company consistently delivers on its product commitments while remaining at the forefront of research and development in the spinal implant industry.
For further information about ChoiceSpine and its products, please visit www.choicespine.com.
About Altus Capital Partners:
Altus Capital Partners is a private equity firm specializing in middle-market manufacturing businesses. With an exclusive focus on manufacturing, Altus Capital Partners possesses a deep understanding of the sector's unique opportunities and challenges. Their patient and thoughtful investment approach allows them to partner with management teams to achieve growth and success.
To learn more about Altus Capital Partners, visit www.altuscapitalpartners.com.
In conclusion, the introduction of the Blackhawk® Ti Standalone Cervical Spacer System by ChoiceSpine represents a significant advancement in spinal device technology. With its exceptional features and expanded indications, this system offers improved outcomes and a positive surgical experience for patients and surgeons alike. ChoiceSpine's commitment to innovation and its collaborative approach with surgeons and industry partners ensure the continued development of superior spinal devices that enhance the lives of those in need.
Other Posts
- The Changing Tide: Archford Capital Strategies, LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Analyzing Icon Wealth Partners, LLC's Q1-Q2 2022 Holdings: Winners, Losers, and Surprises
- Kohlberg Acquires Majority Stake in Worldwide Clinical Trials: A New Era of Growth Begins
- Mountaingate Capital Partners with Damotech and Mac Rak to Lead the Rack Safety Industry
- Comparing Wooster Corthell Wealth Management's 13F Holdings in Q4 2022 and Q1 2023
- Investing in the Tech Giants: MayTech's Q3 vs. Q4 2022 13F Holdings Comparison
- Revamping Investment Strategies: A Comparison of ACK Asset Management's Q3 and Q4 2022 Holdings
- Unveiling the Dynamic Shifts: Courage Miller Partners' Investment Moves from Q4 2023 to Q1 2024
- Navigating the Winds of Change: How McRae Capital Management Adjusted its Portfolio
- GHP Investment Advisors, Inc. Q2 2023 vs. Q3 2023: A Comprehensive Analysis of 13F Holdings